Glaukos Corporation Promotes Chris M. Calcaterra to Chief Operating Officer
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that Chris M. Calcaterra has been named Chief Operating Officer, effective immediately. Mr. Calcaterra joined Glaukos in 2008 and has served as its Chief Commercial Officer since that time. With his promotion to Chief Operating Off